Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX) has announced plans to hold a Research and Development (R&D) Day on Tuesday, September 22, 2026, in New York City. The event will take place from 8:30 a.m. to 12:30 p.m. EDT. This initiative aims to showcase the company's advancements and innovations in the pharmaceutical industry. Participants can expect a comprehensive overview of Telix's latest projects and strategies during the half-day event.